12th International Symposium on Febrile Neutropenia

12. 3. 2010 - 13. 3. 2010, Luxembourg, Luxembourg

Aktivní účast

Registrace

Friday, 12 March 2010
8:00
Introduction

Session I: Prophylactic versus empiric or preemptive therapy of fungal infections Chair: J. Peter Donnelly, PhD

8:10
State-of-the art lecture: Pre-emptive versus empirical anti-fungal therapy in neutropenic cancer patients

8:55
Discussion

9:10
Break

9:30
Oral abstracts

10:20
Case presentation

11:10
Session chair’s summary

11:15
Lunch break

Session II: Replacement antibiotics for therapy of infections caused by resistant bacteria Chair: Jean A. Klastersky, MD, PhD

13:30
State-of-the art lecture: Treatment of antibiotic-resistant bacteria: A major challenge for the next decade

14:15
Discussion

14:30
Break

14:50
Oral abstracts

15:40
Case presentation

16:30
Session chair’s summary

16:40
Adjourn

Saturday, 13 March 2010
8:00
Welcome and introduction to day two

Session III: The role of native immunity on susceptibility and severity of infection Chair: John R. Wingard, MD
8:10
State-of-the art lecture: Why do some neutropenic patients get sick and others do not? The role of innate immunity polymorphisms

8:55
Discussion

9:10
Break

9:30
Oral abstracts

10:20
Case presentation

11:10
Session chair’s summary

11:15
Lunch break

Session IV: Infections related to alternative transplant procedures Chair: Miguel A. Sanz, MD, PhD

13:30
State-of-the art lecture: Infections in patients undergoing stem cell transplant from alternative sources and donors

14:15
Discussion

14:30
Break

14:50
Oral abstracts

15:40
Case presentation

16:30
Session chair’s summary

16:40
Adjourn

Kontakt: meetings@imedex.com

Web: http://www.imedex....ements/a135-01.asp

  • Sdílejte na:
    • Facebook
    • Twitter
    • Del.icio.us
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live